Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chronic kidney disease

Should sodium intake be restricted in patients with CKD?

A Correction to this article was published on 19 September 2016

This article has been updated

A reduction of salt intake to <5 g sodium chloride per day is generally advised for patients with chronic kidney disease. However, hard evidence to support this recommendation is lacking. New data from Fan et al. suggest that very strict sodium limits might be harmful in patients with renal disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Potentially beneficial (green) and potentially deleterious (pink) effects of low dietary sodium intake on renal function.

Change history

  • 19 September 2016

    In the original published version of this article, a description of the association between urinary sodium excretion and kidney failure in patients with 24 h urinary sodium excretion <3 g per day was incorrect. The description has been corrected to read “Although no association was found between 24 h urinary sodium excretion and kidney failure in patients with urinary sodium excretion >3 g per day, when 24 h urinary sodium excretion was <3g per day, a 1g per day higher urine sodium was associated with a 72% increased risk of kidney failure in patients with baseline proteinuria <1g per day, and a 39% lower risk of kidney failure in patients with baseline proteinuria ≥1g per day.” The error has been corrected in the HTML and PDF versions of the article

References

  1. He, F. J. & MacGregor, G. A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 378, 380–382 (2011).

    Article  Google Scholar 

  2. O'Donnell, M. J. et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306, 2229–2238 (2011).

    Article  CAS  Google Scholar 

  3. Stolarz-Skrzypek, K. et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305, 1777–1785 (2011).

    Article  CAS  Google Scholar 

  4. Fan, L., Tighiouart, H., Levey, A. S., Beck, G. J. & Sarnak, M. J. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. http://dx.doi.org/10.1038/ki.2014.59.

  5. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. Suppl. 2, 337–414 (2012).

  6. Kotchen, T. A., Colwley, A. W. & Frohlich, E. D. Salt in health and disease—a delicate balance. N. Engl. J. Med. 368, 1229–1237 (2013).

    Article  CAS  Google Scholar 

  7. Sarafidis, P. A. & Ruilope, L. M. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 85, 536–546 (2014).

    Article  CAS  Google Scholar 

  8. Lambers Heerspink, H. J. et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 82, 330–337 (2012).

    Article  Google Scholar 

  9. Pruijm, M. et al. Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 55, 1116–1122 (2010).

    Article  CAS  Google Scholar 

  10. Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23, 165–173 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

G.W.'s research is supported by Ambizione grants from the Swiss National Science Foundation (PZ00P3_121656 and PZ00P3_13262).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michel Burnier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burnier, M., Wuerzner, G. Should sodium intake be restricted in patients with CKD?. Nat Rev Nephrol 10, 363–364 (2014). https://doi.org/10.1038/nrneph.2014.88

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2014.88

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing